Berlin
Germany
Robert Koch Institute
COVID-19, vaccine effectiveness, SARS-CoV-2, Europe
COVID-19, SARS-CoV-2, Vaccine effectiveness, Primary care, Case-control study, Test-negative design, Multi-country study